Evens AM - Search Results

1

The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future.

Evens AM, Tallman MS, Gartenhaus RB. Evens AM, et al. Leuk Res. 2004 Sep;28(9):891-900. doi: 10.1016/j.leukres.2004.01.011. Leuk Res. 2004. PMID: 15234563 Review.

2

Molecular etiology of mature T-cell non-Hodgkin's lymphomas.

Evens AM, Gartenhaus RB. Evens AM, et al. Front Biosci. 2003 Jan 1;8:d156-75. doi: 10.2741/922. Front Biosci. 2003. PMID: 12456315 Review.

3

Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies.

Shi B, Hsu HL, Evens AM, Gordon LI, Gartenhaus RB. Shi B, et al. Among authors: evens am. Blood. 2003 Jul 1;102(1):297-302. doi: 10.1182/blood-2002-11-3486. Epub 2003 Mar 13. Blood. 2003. PMID: 12637315 Free article.

4

Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.

Evens AM, Prachand S, Shi B, Paniaqua M, Gordon LI, Gartenhaus RB. Evens AM, et al. Clin Cancer Res. 2004 Feb 15;10(4):1481-91. doi: 10.1158/1078-0432.ccr-1058-03. Clin Cancer Res. 2004. PMID: 14977852

5

Treatment of T-cell non-Hodgkin's lymphoma.

Evens AM, Gartenhaus RB. Evens AM, et al. Curr Treat Options Oncol. 2004 Aug;5(4):289-303. doi: 10.1007/s11864-004-0020-8. Curr Treat Options Oncol. 2004. PMID: 15233906 Review.

6

Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells.

Evens AM, Lecane P, Magda D, Prachand S, Singhal S, Nelson J, Miller RA, Gartenhaus RB, Gordon LI. Evens AM, et al. Blood. 2005 Feb 1;105(3):1265-73. doi: 10.1182/blood-2004-03-0964. Epub 2004 Sep 23. Blood. 2005. PMID: 15388578 Free article.

7

Pure red-cell aplasia and epoetin therapy.

Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N. Bennett CL, et al. Among authors: evens am. N Engl J Med. 2004 Sep 30;351(14):1403-8. doi: 10.1056/NEJMoa040528. N Engl J Med. 2004. PMID: 15459301 Free article.

8

Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?

Gidron A, Verma A, Doyle M, Boggio L, Evens A, Gordon L, Singhal S, Tallman M, Williams S, Winter J, Mehta J. Gidron A, et al. Bone Marrow Transplant. 2005 Feb;35(3):243-6. doi: 10.1038/sj.bmt.1704781. Bone Marrow Transplant. 2005. PMID: 15580281

9

The Research on Adverse Drug Events and Reports (RADAR) project.

Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW. Bennett CL, et al. Among authors: evens am. JAMA. 2005 May 4;293(17):2131-40. doi: 10.1001/jama.293.17.2131. JAMA. 2005. PMID: 15870417

10

Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignancies.

Evens AM, Balasubramanian L, Gordon LI. Evens AM, et al. Curr Treat Options Oncol. 2005 Jul;6(4):289-96. doi: 10.1007/s11864-005-0033-y. Curr Treat Options Oncol. 2005. PMID: 15967082 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page